Environmental chemicals and breast cancer risk - A structural chemistry perspective

Current Medicinal Chemistry

Volumn 15, Issue 26, 2008, Pages 2680-2701

  Weyandt, Jamie ^a   Ellsworth, Rachel E ^b   Hooke, Jeffrey A ^c   Shriver, Craig D ^c   Ellsworth, Darrell L ^a  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Chemistry; DDT; Environmental pollutants; Epidemiology; Organochlorine; Polychlorinated biphenyls; Polycyclic aromatic hydrocarbons

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ASBESTOS; ASBESTOS FIBER; CHLORPHENOTANE; ENVIRONMENTAL CHEMICAL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; HEAVY METAL; HETEROCYCLIC AMINE; ORGANOCHLORINE PESTICIDE; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON; VINYL CHLORIDE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; DNA ADDUCT; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; GENE EXPRESSION; GENOTOXICITY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POLLUTANT; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; XENOBIOTIC METABOLISM;

ANIMALS; BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; OCCUPATIONAL EXPOSURE; RISK;

EID: 61649117572     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708786242930     Document Type: Review

References (224)

1. Paustenbach, D.; Galbraith, D. Biomonitoring: Is body burden relevant to public health? Regul. Toxicol. Pharmacol., 2006, 44, 249-61.
2. Centers for Disease Control and Prevention. Third National Report on Human Exposure to Environmental Chemicals (NCEH publication #05-0725), Department of Health and Human Services: Atlanta, GA, 2005; (http://www.cdc.gov/exposurereport/report.htm).
3. Brody, J.G.; Morello-Frosch, R.; Brown, P.; Rudel, R.A.; Altman, R.G.; Frye, M.; Osimo, C.A.; Pérez, C.; Seryak, L.M. Improving disclosure and consent: "Is it safe?": New ethics for reporting personal exposures to environmental chemicals. Am. J. Public Health, 2007, 97, 1547-54.
4. McLachlan, J.A. Environmental signaling: What embryos and evolution teach us about endocrine disrupting chemicals. Endocr. Rev., 2001, 22, 319-41.
5. Kreiger, N.; Sloan, M.; Cotterchio, M.; Kirsh, V. The risk of breast cancer following reproductive surgery. Eur. J. Cancer, 1999, 35, 97-101.
6. Yue, W.; Santen, R.J.; Wang, J.-P.; Li, Y.; Verderame, M.F.; Bocchinfuso, W.P.; Korach, K.S.; Devanesan, P.; Todorovic, R.; Rogan, E.G.; Cavalieri, E.L. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J. Steroid Biochem. Mol. Biol., 2003, 86, 477-86.
7. Warren, M.P. A comparative review of the risks and benefits of hormone replacement therapy regimens. Am. J. Obstet. Gynecol., 2004, 190, 1141-67.
8. Kielhorn, J.; Melber, C.; Wahnschaffe, U.; Aitio, A.; Mangelsdorf, I. Vinyl chloride: Still a cause for concern. Environ. Health Perspect., 2000, 108, 579-88.
9. Bolt, H.M. Vinyl chloride-a classical industrial toxicant of new interest. Crit. Rev. Toxicol., 2005, 35, 307-23
10. Boffetta, P.; Matisane, L.; Mundt, K.A.; Dell, L.D. Meta-analysis of studies of occupational exposure to vinyl chloride in relation to cancer mortality. Scand. J. Work Environ. Health, 2003, 29, 220-9.
11. Bolt, H.M. Roles of etheno-DNA adducts in tumorigenicity of olefins. Crit. Rev. Toxicol., 1988, 18, 299-309.
12. Barbin, A. Etheno-adduct-forming chemicals: From mutagenicity testing to tumor mutation spectra. Mutat. Res., 2000, 462, 55-69.
13. Weihrauch, M.; Bader, M.; Lehnert, G.; Koch, B.; Wittekind, C.; Wrbitzky, R.; Tannapfel, A. Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. Environ. Mol. Mutagen., 2002, 40, 36-40.
14. Weihrauch, M.; Benicke, M.; Lehnert, G.; Wittekind, C.; Bader, M.; Wrbitzky, R.; Tannapfel, A. High prevalence of K-ras-2 mutations in hepatocellular carcinomas in workers exposed to vinyl chloride. Int. Arch. Occup. Environ. Health, 2001, 74, 405-10
15. Mossman, B.T.; Bignon, J.; Corn, M.; Seaton, A.; Gee, J.B.L. Asbestos: scientific developments and implications for public policy. Science, 1990, 247, 294-301.
16. Cugell, D.W.; Kamp, D.W. Asbestos and the pleura: A review. Chest, 2004, 125, 1103-17.
17. Pisick, E.; Salgia, R. Molecular biology of malignant mesothelioma: A review. Hematol. Oncol. Clin. North Am., 2005, 19, 997-1023.
18. Sterman, D.H.; Albelda, S.M. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology, 2005, 10, 266-83.
19. Hicks, J. Biologic, cytogenetic, and molecular factors in mesothelial proliferations. Ultrastruct. Pathol., 2006, 30, 19-30.
20. Kinnula, V.L. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur. Respir. J., 1999, 14, 706-16.
21. Murthy, S.S.; Testa, J.R. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell. Physiol., 1999, 180, 150-57.
22. Unfried, K.; Schürkes, C.; Abel, J. Distinct spectrum of mutations induced by crocidolite asbestos: Clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res., 2002, 62, 99-104.
23. Robinson, B.W.S.; Lake, R.A. Advances in malignant mesothelioma. N. Engl. J. Med., 2005, 353, 1591-1603.
24. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M.J. Cancer statistics, 2007. CA. Cancer J. Clin., 2007, 57, 43-66.
25. Ries, L.A.G.; Melbert, D.; Krapcho, M.; Mariotto, A.; Miller, B.A.; Feuer, E.J.; Clegg, L.; Horner, M.J.; Howlader, N.; Eisner, M.P.; Reichman, M.; Edwards, B.K., Eds. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute: Bethesda, Maryland, 2007; (http://seer.cancer.gov/csr/1975_2004/).
26. Cancer Trends Progress Report - 2007 Update: Costs of Cancer Care. National Cancer Institute: Bethesda, Maryland, 2007; (http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2007 &chid=75&coid=726&mid=).
27. Scully, R.; Livingston, D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature, 2000, 408, 429-32.
28. Monteiro, A.N.A. BRCA1: Exploring the links to transcription. Trends Biochem. Sci., 2000, 25, 469-74.
29. Claus, E.B.; Schildkraut, J.M.; Thompson, W.D.; Risch, N.J. The genetic attributable risk of breast and ovarian cancer. Cancer, 1996, 77, 2318-24.
30. Hemminki, K.; Granström, C.; Czene, K. Attributable risks for familial breast cancer by proband status and morphology: A nationwide epidemiologic study from Sweden. Int. J. Cancer, 2002, 100, 214-19.
31. Lichtenstein, P.; Holm, N.V.; Verkasalo, P.K.; Iliadou, A.; Kaprio, J.; Koskenvuo, M.; Pukkala, E.; Skytthe, A.; Hemminki, K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 2000, 343, 78-85.
32. Rockhill, B.; Weinberg, C.R.; Newman B. Population attributable fraction estimation for established breast cancer risk factors: Considering the issues of high prevalence and unmodifiability. Am. J. Epidemiol., 1998, 147, 826-33.
33. Key, T.J.; Verkasalo, P.K.; Banks E. Epidemiology of breast cancer. Lancet Oncol., 2001, 2, 133-40.
34. Kaaks, R.; Berrino, F.; Key, T.; Rinaldi, S.; Dossus, L.; Biessy, C.; Secreto, G.; Amiano, P.; Bingham, S.; Boeing, H.; Bueno de Mesquita, H.B.; Chang-Claude, J.; Clavel-Chapelon, F.; Fournier, A.; van Gils, C.H.; Gonzalez, C.A.; Gurrea, A.B.; Critselis, E.; Khaw, K.T.; Krogh, V.; Lahmann, P.H.; Nagel, G.; Olsen, A.; Onland-Moret, N.C.; Overvad, K.; Palli, D.; Panico, S.; Peeters, P.; Quirós, J.R.; Roddam, A.; Thiebaut, A.; Tjønneland, A.; Chirlaque, M.D.; Trichopoulou, A.; Trichopoulos, D.; Tumino, R.; Vineis, P.; Norat, T.; Ferrari, P.; Slimani, N.; Riboli, E. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst., 2005, 97, 755-65.
35. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst., 2002, 94, 606-16.
36. Kaaks, R.; Rinaldi, S.; Key, T.J.; Berrino, F.; Peeters, P.H.M.; Biessy, C.; Dossus, L.; Lukanova, A.; Bingham, S.; Khaw, K.-T.; Allen, N.E.; Bueno-de-Mesquita, H.B.; van Gils, C.H.; Grobbee, D.; Boeing, H.; Lahmann, P.H.; Nagel, G.; Chang-Claude, J.; Clavel-Chapelon, F.; Fournier, A.; Thiébaut, A.; González, C.A.; Quirós, J.R.; Tormo, M.-J.; Ardanaz, E.; Amiano, P.; Krogh, V.; Palli, D.; Panico, S.; Tumino, R.; Vineis, P.; Trichopoulou, A.; Kalapothaki, V.; Trichopoulos, D.; Ferrari, P.; Norat, T.; Saracci, R.; Riboli, E. Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer, 2005, 12, 1071-82.
37. Yager, J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr., 2000, 27, 67-73.
38. Männistö, P.T.; Kaakkola, S. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev., 1999, 51, 593-628
39. Cavalieri, E.L.; Stack, D.E.; Devanesan, P.D.; Todorovic, R.; Dwivedy, I.; Higginbotham, S.; Johansson, S.L.; Patil, K.D.; Gross, M.L.; Gooden, J.K.; Ramanathan, R.; Cerny, R.L.; Rogan, E.G. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 1997, 94, 10937-42
40. Chakravarti, D.; Mailander, P.C.; Li, K.-M.; Higginbotham, S.; Zhang, H.L.; Gross, M.L.; Meza, J.L.; Cavalieri, E.L.; Rogan, E.G. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene, 2001, 20, 7945-53.
41. Cavalieri, E.; Frenkel, K.; Liehr, J.G.; Rogan, E.; Roy, D. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J. Natl. Cancer Inst. Monogr., 2000, 27, 75-93.
42. Jefcoate, C.R.; Liehr, J.G.; Santen, R.J.; Sutter, T.R.; Yager, J.D.; Yue, W.; Santner, S.J.; Tekmal, R.; Demers, L.; Pauley, R.; Naftolin, F.; Mor, G.; Berstein, L. Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr., 2000, 27, 95-112.
43. Demple, B.; Harrison, L. Repair of oxidative damage to DNA: Enzymology and biology. Annu. Rev. Biochem., 1994, 63, 915-48.
44. Djuric, Z.; Heilbrun, L.K.; Simon, M.S.; Smith, D.; Luongo, D.A.; LoRusso, P.M.; Martino, S. Levels of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood as a marker of breast cancer. Cancer 1996, 77, 691-6.
45. Poulsen, H.E. Oxidative DNA modifications. Exp. Toxicol. Pathol., 2005, 57 Suppl 1, 161-9.
46. Malins, D.C.; Polissar, N.L.; Gunselman, S.J. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA, 1996, 93, 2557-63.
47. Yoshie, Y.; Ohshima, H. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: Implications for hormonal carcinogenesis. Free Radic. Biol. Med., 1998, 24, 341-8.
48. Frenkel, K.; Karkoszka, J.; Glassman, T.; Dubin, N.; Toniolo, P.; Taioli, E.; Mooney, L.A.; Kato, I. Serum autoantibodies recognizing 5-hydroxymethyl-2′-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. Cancer Epidemiol. Biomarkers Prev., 1998, 7, 49-57.
49. Yager, J.D.; Davidson, N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 2006, 354, 270-82.
50. Hayashi, S.-I.; Eguchi, H.; Tanimoto, K.; Yoshida, T.; Omoto, Y.; Inoue, A.; Yoshida, N.; Yamaguchi, Y. The expression and function of estrogen receptor α and β in human breast cancer and its clinical application. Endocr. Relat. Cancer, 2003, 10, 193-202.
51. Levin, E.R. Cellular functions of plasma membrane estrogen receptors. Steroids, 2002, 67, 471-5.
52. Levin, E.R. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol. Endocrinol., 2003, 17, 309-17.
53. Ziegler, R.G.; Hoover, R.N.; Pike, M.C.; Hildesheim, A.; Nomura, A.M.; West, D.W.; Wu-Williams, A.H.; Kolonel, L.N.; Horn-Ross, P.L.; Rosenthal, J.F.; Hyer, M.B. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst., 1993, 85, 1819-27.
54. Brody, J.G.; Rudel, R.A.; Michels, K.B.; Moysich, K.B.; Bernstein, L.; Attfield, K.R.; Gray, S. Environmental pollutants, diet, physical activity, body size, and breast cancer: Where do we stand in research to identify opportunities for prevention? Cancer, 2007, 109 Suppl 12, 2627-34.
55. Blair, R.M.; Fang, H.; Branham, W.S.; Hass, B.S.; Dial, S.L.; Moland, C.L.; Tong, W.; Shi, L.; Perkins, R.; Sheehan, D.M. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci., 2000, 54, 138-53.
56. Sonnenschein, C.; Soto, A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol., 1998, 65, 143-50.
57. Hoyer, A.P.; Grandjean, P.; Jørgensen, T.; Brock, J.W.; Hartvig, H.B. Organochlorine exposure and risk of breast cancer. Lancet, 1998, 352, 1816-20.
58. Zou, E.; Matsumura, F. Long-term exposure to β-hexachlorocyclohexane (β-HCH) promotes transformation and invasiveness of MCF-7 human breast cancer cells. Biochem. Pharmacol., 2003, 66, 831-40.
59. Ibarluzea, J.M.; Fernández, M.F.; Santa-Marina, L.; Olea-Serrano, M.F.; Rivas, A.M.; Aurrekoetxea, J.J.; Expósito, J.; Lorenzo, M.; Torné P.; Villalobos, M.; Pedraza, V.; Sasco, A.J.; Olea, N. Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control, 2004, 15, 591-600.
60. Li, Q.Q.; Loganath, A.; Chong, Y.S.; Tan, J.; Obbard, J.P. Persistent organic pollutants and adverse health effects in humans. J. Toxicol. Environ. Health A, 2006, 69, 1987-2005.
61. Jaga, K.; Dharmani, C. Global surveillance of DDT and DDE levels in human tissues. Int. J. Occup. Med. Environ. Health, 2003, 16, 7-20.
62. Kannan, K.; Tanabe, S.; Giesy, J.P.; Tatsukawa, R. Organochlorine pesticides and polychlorinated biphenyls in foodstuffs from Asian and oceanic countries. Rev. Environ. Contam. Toxicol., 1997, 152, 1-55.
63. Smith, A.G. In Handbook of Pesticide Toxicology, Second Edition; Krieger, R., Ed.; Academic Press: San Diego, California, 2001; pp. 1305-55.
64. Garabrant, D.H.; Held, J.; Langholz, B.; Peters, J.M.; Mack, T.M. DDT and related compounds and risk of pancreatic cancer. J. Natl. Cancer Inst., 1992, 84, 764-71.
65. Cocco, P.; Blair, A.; Congia, P.; Saba, G.; Ecca, A.R.; Palmas, C. Long-term health effects of the occupational exposure to DDT: A preliminary report. Ann. N. Y. Acad. Sci., 1997, 837, 246-56.
66. Occupational Exposures in Insecticide Application, and Some Pesticides; In IARC monographs on the evaluation of carcinogenic risks to humans; World Health Organization: Lyon, France, 1991; Vol. 53, pp. 179-250.
67. Report on Carcinogens, Eleventh Edition. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, 2005; (http://ntp.niehs.nih.gov/index.cfm?objectid= 32BA9724-F1F6-975E-7FCE50709CB4C932).
68. Wolff, M.S.; Zeleniuch-Jacquotte, A.; Dubin, N.; Toniolo, P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 271-7.
69. Matthews, H.B.; Anderson, M.W. Effect of chlorination on the distribution and excretion of polychlorinated biphenyls. Drug Metab. Dispos., 1975, 3, 371-80.
70. Van den Berg, M.; Birnbaum, L.; Bosveld, A.T.C.; Brunstrom, B.; Cook, P.; Feeley, M.; Giesy, J.P.; Hanberg, A.; Hasegawa, R.; Kennedy, S.W.; Kubiak, T.; Larsen, J.C.; van Leeuwen, F.X.R.; Liem, A.K.D.; Nolt, C.; Peterson, R.E.; Poellinger, L.; Safe, S.; Schrenk, D.; Tillitt, D.; Tysklind, M.; Younes, M.; Wærn, F.; Zacharewski, T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect., 1998, 106, 775-92.
71. McFarland, V.A.; Clarke, J.U. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: Considerations for a congener-specific analysis. Environ. Health Perspect., 1989, 81, 225-39.
72. Wolff, M.S.; Toniolo, P.G. Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ. Health Perspect., 1995, 103 Suppl 7, 141-5.
73. Safe, S.H. Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol., 1994, 24, 87-149.
74. Birnbaum, L.S.; DeVito, M.J. Use of toxic equivalency factors for risk assessment for dioxins and related compounds. Toxicology, 1995, 105, 391-401.
75. Snedeker, S.M. Pesticides and breast cancer risk: A review of DDT, DDE, and dieldrin. Environ. Health Perspect., 2001, 109 Suppl 1, 35-47.
76. Turusov, V.; Rakitsky, V.; Tomatis, L. Dichlorodiphenyltrichloroethane (DDT): Ubiquity, persistence, and risks. Environ. Health Perspect., 2002, 110, 125-8.
77. Rogan, W.J.; Chen, A. Health risks and benefits of bis(4chlorophenyl)- 1,1,1-trichloroethane (DDT). Lancet, 2005, 366, 763-73.
78. Brody, J.G.; Moysich, K.B.; Humblet, O.; Attfield, K.R.; Beehler, G.P.; Rudel, R.A. Environmental pollutants and breast cancer: Epidemiologic studies. Cancer, 2007, 109 Suppl 12, 2667-711.
79. López-Cervantes, M.; Torres-Sánchez, L.; Tobías, A.; LópezCarrillo, L. Dichlorodiphenyldichloroethane burden and breast cancer risk: A meta-analysis of the epidemiologic evidence. Environ. Health Perspect., 2004, 112, 207-14.
80. Laden, F.; Collman, G.; Iwamoto, K.; Alberg, A.J.; Berkowitz, G.S.; Freudenheim, J.L.; Hankinson, S.E.; Helzlsouer, K.J.; Holford, T.R.; Huang, H.-Y.; Moysich, K.B.; Tessari, J.D.; Wolff, M.S.; Zheng, T.; Hunter, D.J. 1,1-Dichloro-2,2-bis(pchlorophenyl) ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies. J. Natl. Cancer Inst., 2001, 93, 768-76.
81. Moysich, K.B.; Ambrosone, C.B.; Vena, J.E.; Shields, P.G.; Mendola, P.; Kostyniak, P.; Greizerstein, H.; Graham, S.; Marshall, J.R.; Schisterman, E.F.; Freudenheim, J.L. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 1998, 7, 181-8.
82. Laden, F.; Hankinson, S.E.; Wolff, M.S.; Colditz, G.A.; Willett, W.C.; Speizer, F.E.; Hunter, D.J. Plasma organochlorine levels and the risk of breast cancer: An extended follow-up in the Nurses' Health Study. Int. J. Cancer, 2001, 91, 568-74.
83. Helzlsouer, K.J.; Alberg, A.J.; Huang, H.-Y.; Hoffman, S.C.; Strickland, P.T.; Brock, J.W.; Burse, V.W.; Needham, L.L.; Bell, D.A.; Lavigne, J.A.; Yager, J.D.; Comstock, G.W. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol. Biomarkers Prev., 1999, 8, 525-32.
84. Wolff, M.S.; Berkowitz, G.S.; Brower, S.; Senie, R.; Bleiweiss, I.J.; Tartter, P.; Pace, B.; Roy, N.; Wallenstein, S.; Weston, A. Organochlorine exposures and breast cancer risk in New York City women. Environ. Res., 2000, 84, 151-61.
85. Zheng, T.; Holford, T.R.; Mayne, S.T.; Tessari, J.; Ward, B.; Carter, D.; Owens, P.H.; Boyle, P.; Dubrow, R.; Archibeque-Engle, S.; Dawood, O.; Zahm, S.H. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′- bis(p-chlorophenyl)ethylene. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 167-74.
86. Krieger, N.; Wolff, M.S.; Hiatt, R.A.; Rivera, M.; Vogelman, J.; Orentreich, N. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women. J. Natl. Cancer Inst., 1994, 86, 589-99.
87. Dorgan, J.F.; Brock, J.W.; Rothman, N.; Needham, L.L.; Miller, R.; Stephenson, H.E., Jr.; Schussler, N.; Taylor, P.R. Serum organochlorine pesticides and PCBs and breast cancer risk: Results from a prospective analysis (USA). Cancer Causes Control, 1999, 10, 1-11.
88. Ward, E.M.; Schulte, P.; Grajewski, B.; Andersen, A.; Patterson, D.G., Jr.; Turner, W.; Jellum, E.; Deddens, J.A.; Friedland, J.; Roeleveld, N.; Waters, M.; Butler, M.A.; DiPietro, E.; Needham, L.L. Serum organochlorine levels and breast cancer: A nested casecontrol study of Norwegian women. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 1357-67.
89. Gammon, M.D.; Wolff, M.S.; Neugut, A.I.; Eng, S.M.; Teitelbaum, S.L.; Britton, J.A.; Terry, M.B.; Levin, B.; Stellman, S.D.; Kabat, G.C.; Hatch, M.; Senie, R.; Berkowitz, G.; Bradlow, H.L.; Garbowski, G.; Maffeo, C.; Montalvan, P.; Kemeny, M.; Citron, M.; Schnabel, F.; Schuss, A.; Hajdu, S.; Vinceguerra, V.; Niguidula, N.; Ireland, K.; Santella, R.M. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 686-97.
90. Zheng, T.; Holford, T.R.; Mayne, S.T.; Ward, B.; Carter, D.; Owens, P.H.; Dubrow, R.; Zahm, S.H.; Boyle, P.; Archibeque, S.; Tessari, J. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am. J. Epidemiol., 1999, 150, 453-8.
91. Zheng, T.; Holford, T.R.; Tessari, J.; Mayne, S.T.; Owens, P.H.; Ward, B.; Carter, D.; Boyle, P.; Dubrow, R.; Archibeque-Engle, S.; Zahm, S.H. Breast cancer risk associated with congeners of polychlorinated biphenyls. Am. J. Epidemiol., 2000, 152, 50-8.
92. Raaschou-Nielsen, O.; Pavuk, M.; LeBlanc, A.; Dumas, P.; Philippe Weber, J.; Olsen, A.; Tjønneland, A.; Overvad, K.; Olsen, J.H. Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 67-74.
93. Holford, T.R.; Zheng, T.; Mayne, S.T.; Zahm, S.H.; Tessari, J.D.; Boyle, P. Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk. Int. J. Epidemiol., 2000, 29, 975-82.
94. Aronson, K.J.; Miller, A.B.; Woolcott, C.G.; Sterns, E.E.; McCready, D.R.; Lickley, L.A.; Fish, E.B.; Hiraki, G.Y.; Holloway, C.; Ross, T.; Hanna, W.M.; SenGupta, S.K.; Weber, J.-P. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 2000, 9, 55-63.
95. Lucena, R.A.; Allam, M.F.; Costabeber, I.H.; Villarejo, M.L.J.; Navajas, R.F.C. Breast cancer risk factors: PCB congeners. Eur. J. Cancer Prev., 2001, 10, 117-9.
96. Charlier, C.; Pitance, F.; Plomteux, G. PCB residues in a breast cancer patient population. Bull. Environ. Contam. Toxicol., 2003, 71, 887-91.
97. Demers, A.; Ayotte, P.; Brisson, J.; Dodin, S.; Robert, J.; Dewailly, E. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: A congener-specific analysis. Am. J. Epidemiol., 2002, 155, 629-35.
98. Muscat, J.E.; Britton, J.A.; Djordjevic, M.V.; Citron, M.L.; Kemeny, M.; Busch-Devereaux, E.; Pittman, B.; Stellman, S.D. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 1474-8.
99. Woolcott, C.G.; Aronson, K.J.; Hanna, W.M.; SenGupta, S.K.; McCready, D.R.; Sterns, E.E.; Miller, A.B. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control, 2001, 12, 395-404.
100. Moysich, K.B.; Shields, P.G.; Freudenheim, J.L.; Schisterman, E.F.; Vena, J.E.; Kostyniak, P.; Greizerstein, H.; Marshall, J.R.; Graham, S.; Ambrosone, C.B. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 1999, 8, 41-4.
101. Laden, F.; Ishibe, N.; Hankinson, S.E.; Wolff, M.S.; Gertig, D.M.; Hunter, D.J.; Kelsey, K.T. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 1560-5.
102. Zhang, Y.; Wise, J.P.; Holford, T.R.; Xie, H.; Boyle, P.; Zahm, S.H.; Rusiecki, J.; Zou, K.; Zhang, B.; Zhu, Y.; Owens, P.H.; Zheng, T. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am. J. Epidemiol., 2004, 160, 1177-83.
103. Cosma, G.; Crofts, F.; Taioli, E.; Toniolo, P.; Garte, S. Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Health, 1993, 40, 309-16.
104. Firozi, P.F.; Bondy, M.L.; Sahin, A.A.; Chang, P.; Lukmanji, F.; Singletary, E.S.; Hassan, M.M.; Li, D. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis, 2002, 23, 301-6.
105. Endocrine Disruptor Screening Program. United States Environmental Protection Agency; (http://www.epa.gov/scipoly/oscpendo).
106. Endocrine Disruptors Website. European Commission, Environment Directorate General; (http://ec.europa.eu/environment/endocrine/ strategy/substances_en.htm).
107. Elder, R.L. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, and butylparaben. J. Am. Coll. Toxicol., 1984, 3, 147-209.
108. Rastogi, S.C.; Schouten, A.; de Kruijf, N.; Weijland, J.W. Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact Dermatitis, 1995, 32, 28-30.
109. Carl, K.; Felger, C.B. Antiperspirants and Deodorants (Cosmetic Science and Technology Series, Volume 7); Marcel Dekker: New York, 1988.
110. McGrath, K.G. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur. J. Cancer Prev., 2003, 12, 479-85.
111. Darbre, P.D. Underarm cosmetics and breast cancer. J. Appl. Toxicol., 2003, 23, 89-95.
112. Darbre, P.D.; Aljarrah, A.; Miller, W.R.; Coldham, N.G.; Sauer, M.J.; Pope, G.S. Concentrations of parabens in human breast tumours. J. Appl. Toxicol., 2004, 24, 5-13.
113. Harvey, P.W.; Darbre, P. Endocrine disrupters and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J. Appl. Toxicol., 2004, 24, 167-76.
114. Darbre, P.D. Environmental oestrogens, cosmetics and breast cancer. Best Pract. Res. Clin. Endocrinol. Metab., 2006, 20, 121-43.
115. Rimsten, A. Symptoms and signs in benign and malignant tumours of the breast. Ups. J. Med. Sci., 1976, 81, 54-60.
116. Ellsworth, D.L.; Ellsworth, R.E.; Love, B.; Deyarmin, B.; Lubert, S.M.; Mittal, V.; Hooke, J.A.; Shriver, C.D. Outer breast quadrants demonstrate increased levels of genomic instability. Ann. Surg. Oncol., 2004, 11, 861-8.
117. Darbre, P.D. Recorded quadrant incidence of female breast cancer in Great Britain suggests a disproportionate increase in the upper outer quadrant of the breast. Anticancer Res., 2005, 25, 2543-50.
118. Soni, M.G.; Carabin, I.G.; Burdock, G.A. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem. Toxicol., 2005, 43, 985-1015.
119. Routledge, E.J.; Parker, J.; Odum, J.; Ashby, J.; Sumpter, J.P. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol., 1998, 153, 12-9.
120. Okubo, T.; Yokoyama, Y.; Kano, K.; Kano, I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERα and PR. Food Chem. Toxicol., 2001, 39, 1225-32.
121. Byford, J.R.; Shaw, L.E.; Drew, M.G.B.; Pope, G.S.; Sauer, M.J.; Darbre, P.D. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 2002, 80, 49-60
122. Gomez, E.; Pillon, A.; Fenet, H.; Rosain, D.; Duchesne, M.J.; Nicolas, J.C.; Balaguer, P.; Casellas, C. Estrogenic activity of cosmetic components in reporter cell lines: Parabens, UV screens, and musks. J. Toxicol. Environ. Health A, 2005, 68, 239-51.
123. Golden, R.; Gandy, J.; Vollmer, G. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol., 2005, 35, 435-58.
124. Darbre, P.D.; Byford, J.R.; Shaw, L.E.; Horton, R.A.; Pope, G.S.; Sauer, M.J. Oestrogenic activity of isobutylparaben in vitro and in vivo. J. Appl. Toxicol., 2002, 22, 219-26.
125. Darbre, P.D.; Byford, J.R.; Shaw, L.E.; Hall, S.; Coldham, N.G.; Pope, G.S.; Sauer, M.J. Oestrogenic activity of benzylparaben. J. Appl. Toxicol., 2003, 23, 43-51.
126. Terasaka, S.; Inoue, A.; Tanji, M.; Kiyama, R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol. Lett., 2006, 163, 130-41.
127. Pugazhendhi, D.; Sadler, A.J.; Darbre, P.D. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17β-oestradiol in MCF7 human breast cancer cells. J. Appl. Toxicol., 2007, 27, 67-77.
128. Mirick, D.K.; Davis, S.; Thomas, D.B. Antiperspirant use and the risk of breast cancer. J. Natl. Cancer Inst., 2002, 94, 1578-80.
129. Harvey, P.W.; Everett, D.J. Regulation of endocrine-disrupting chemicals: Critical overview and deficiencies in toxicology and risk assessment for human health. Best Pract. Res. Clin. Endocrinol. Metab., 2006, 20, 145-65.
130. Extended Opinion on Parabens, Underarm Cosmetics and Breast Cancer. Scientific Committee on Consumer Products (SCCP), European Commission, Health & Consumer Protection Directorate- General, 2005.
131. Ross, G. A perspective on the safety of cosmetic products: A position paper of the American Council on Science and Health. Int. J. Toxicol., 2006, 25, 269-77.
132. Bergfeld, W.F.; Belsito, D.V.; Marks, J.G., Jr.; Andersen, F.A. Safety of ingredients used in cosmetics. J. Am. Acad. Dermatol., 2005, 52, 125-32.
133. Mumtaz, M.M.; George, J.D.; Gold, K.W.; Cibulas, W.; DeRosa, C.T. ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): Understanding a complex problem. Toxicol. Ind. Health, 1996, 12, 742-971.
134. Castaño-Vinyals, G.; D'Errico, A.; Malats, N.; Kogevinas, M. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup. Environ. Med., 2004, 61, e12.
135. El-Bayoumy, K. Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol., 1992, 5, 585-90.
136. Bonner, M.R.; Han, D.; Nie, J.; Rogerson, P.; Vena, J.E.; Muti, P.; Trevisan, M.; Edge, S.B.; Freudenheim, J.L. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 53-60.
137. Lewis-Michl, E.L.; Melius, J.M.; Kallenbach, L.R.; Ju, C.L.; Talbot, T.O.; Orr, M.F.; Lauridsen, P.E. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York. Arch. Environ. Health, 1996, 51, 255-65.
138. Gammon, M.D.; Santella, R.M.; Neugut, A.I.; Eng, S.M.; Teitelbaum, S.L.; Paykin, A.; Levin, B.; Terry, M.B.; Young, T.L.; Wang, L.W.; Wang, Q.; Britton, J.A.; Wolff, M.S.; Stellman, S.D.; Hatch, M.; Kabat, G.C.; Senie, R.; Garbowski, G.; Maffeo, C.; Montalvan, P.; Berkowitz, G.; Kemeny, M.; Citron, M.; Schnabel, F.; Schuss, A.; Hajdu, S.; Vinceguerra, V. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 677-85.
139. Rundle, A.; Tang, D.; Hibshoosh, H.; Schnabel, F.; Kelly, A.; Levine, R.; Zhou, J.; Link, B.; Perera, F. Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Environ. Mol. Mutagen., 2002, 39, 201-7.
140. Gammon, M.D.; Sagiv, S.K.; Eng, S.M.; Shantakumar, S.; Gaudet, M.M.; Teitelbaum, S.L.; Britton, J.A.; Terry, M.B.; Wang, L.W.; Wang, Q.; Stellman, S.D.; Beyea, J.; Hatch, M.; Kabat, G.C.; Wolff, M.S.; Levin, B.; Neugut, A.I.; Santella, R.M. Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: A pooled analysis. Arch. Environ. Health, 2004, 59, 640-9.
141. Poirier, M.C.; Santella, R.M.; Weston, A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis, 2000, 21, 353-9.
142. Rundle, A.; Tang, D.; Zhou, J.; Cho, S.; Perera, F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 1079-85.
143. Tang, D.; Cho, S.; Rundle, A.; Chen, S.; Phillips, D.; Zhou, J.; Hsu, Y.; Schnabel, F.; Estabrook, A.; Perera, F.P. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res. Treat., 2002, 75, 159-66.
144. Terry, M.B.; Gammon, M.D.; Zhang, F.F.; Eng, S.M.; Sagiv, S.K.; Paykin, A.B.; Wang, Q.; Hayes, S.; Teitelbaum, S.L.; Neugut, A.I.; Santella, R.M. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 2053-8
145. Shen, J.; Gammon, M.D.; Terry, M.B.; Wang, L.; Wang, Q.; Zhang, F.; Teitelbaum, S.L.; Eng, S.M.; Sagiv, S.K.; Gaudet, M.M.; Neugut, A.I.; Santella, R.M. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 336-42.
146. Felton, J.S.; Knize, M.G.; Bennett, L.M.; Malfatti, M.A.; Colvin, M.E.; Kulp, K.S. Impact of environmental exposures on the mutagenicity/ carcinogenicity of heterocyclic amines. Toxicology, 2004, 198, 135-45.
147. DeBruin, L.S.; Josephy, P.D. Perspectives on the chemical etiology of breast cancer. Environ. Health Perspect., 2002, 110 Suppl 1, 119-28.
148. Schut, H.A.J.; Snyderwine, E.G. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis. Carcinogenesis, 1999, 20, 353-68.
149. Tanaka, T.; Barnes, W.S.; Williams, G.M.; Weisburger, J.H. Multipotential carcinogenicity of the fried food mutagen 2-amino-3- methylimidazo[4,5-f]quinoline in rats. Jpn. J. Cancer Res., 1985, 76, 570-6.
150. Kato, T.; Migita, H.; Ohgaki, H.; Sato, S.; Takayama, S.; Sugimura, T. Induction of tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis, 1989, 10, 601-3.
151. Ito, N.; Hasegawa, R.; Sano, M.; Tamano, S.; Esumi, H.; Takayama, S.; Sugimura, T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 1991, 12, 1503-6.
152. Nagao, M.; Ushijima, T.; Wakabayashi, K.; Ochiai, M.; Kushida, H.; Sugimura, T.; Hasegawa, R.; Shirai, T.; Ito, N. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods. Cancer, 1994, 74 Suppl 3, 1063-9.
153. Kakiuchi, H.; Watanabe, M.; Ushijima, T.; Toyota, M.; Imai, K.; Weisburger, J.H.; Sugimura, T.; Nagao, M. Specific 5′-GGGA-3′- >5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl. Acad. Sci. USA, 1995, 92, 910-4.
154. Roberts-Thomson, S.J.; Snyderwine, E.G. Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Mol. Carcinog., 1997, 20, 348-54.
155. Bennion, B.J.; Cosman, M.; Lightstone, F.C.; Knize, M.G.; Montgomery, J.L.; Bennett, L.M.; Felton, J.S.; Kulp, K.S. PhIP carcinogenicity in breast cancer: Computational and experimental evidence for competitive interactions with human estrogen receptor. Chem. Res. Toxicol., 2005, 18, 1528-36.
156. Snyderwine, E.G.; Venugopal, M.; Yu, M. Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res., 2002, 506-507, 145-52.
157. Vatten, L.J.; Solvoll, K.; Løken, E.B. Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 Norwegian women. Int. J. Cancer, 1990, 46, 12-5
158. Toniolo, P.; Riboli, E.; Shore, R.E.; Pasternack, B.S. Consumption of meat animal products, protein, and fat and risk of breast cancer: A prospective cohort study in New York. Epidemiology, 1994, 5, 391-7.
159. Knekt, P.; Steineck, G.; Järvinen, R.; Hakulinen, T.; Aromaa, A. Intake of fried meat and risk of cancer: A follow-up study in Finland. Int. J. Cancer, 1994, 59, 756-60.
160. De Stefani, E.; Ronco, A.; Mendilaharsu, M.; Guidobono, M.; Deneo-Pellegrini, H. Meat intake, heterocyclic amines, and risk of breast cancer: A case-control study in Uruguay. Cancer Epidemiol. Biomarkers Prev., 1997, 6, 573-81.
161. Zheng, W.; Gustafson, D.R.; Sinha, R.; Cerhan, J.R.; Moore, D.; Hong, C.-P.; Anderson, K.E.; Kushi, L.H.; Sellers, T.A.; Folsom, A.R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst., 1998, 90, 1724-9.
162. Sinha, R.; Gustafson, D.R.; Kulldorff, M.; Wen, W.-Q.; Cerhan, J.R.; Zheng, W. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J. Natl. Cancer Inst., 2000, 92, 1352-4.
163. Pfau, W.; O'Hare, M.J.; Grover, P.L.; Phillips, D.H. Metabolic activation of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) to DNA binding species in human mammary epithelial cells. Carcinogenesis, 1992, 13, 907-9.
164. Lightfoot, T.J.; Coxhead, J.M.; Cupid, B.C.; Nicholson, S.; Garner, R.C. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutat. Res., 2000, 472, 119-27
165. Sadrieh, N.; Davis, C.D.; Snyderwine, E.G. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res., 1996, 56, 2683-7.
166. Zheng, W.; Deitz, A.C.; Campbell, D.R.; Wen, W.-Q.; Cerhan, J.R.; Sellers, T.A.; Folsom, A.R.; Hein, D.W. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 1999, 8, 233-9.
167. Deitz, A.C.; Zheng, W.; Leff, M.A.; Gross, M.; Wen, W.-Q.; Doll, M.A.; Xiao, G.H.; Folsom, A.R.; Hein, D.W. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 905-10.
168. Gertig, D.M.; Hankinson, S.E.; Hough, H.; Spiegelman, D.; Colditz, G.A.; Willett, W.C.; Kelsey, K.T.; Hunter, D.J. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int. J. Cancer, 1999, 80, 13-7.
169. Delfino, R.J.; Sinha, R.; Smith, C.; West J.; White, E.; Lin, H.J.; Liao, S.-Y.; Gim, J.S.Y.; Ma, H.L.; Butler, J.; Anton-Culver, H. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis, 2000, 21, 607-15.
170. Kazantzis, G. Role of cobalt, iron, lead, manganese, mercury, platinum, selenium, and titanium in carcinogenesis. Environ. Health Perspect., 1981, 40, 143-61.
171. Vesterberg, O.; Alessio, L.; Brune, D.; Gerhardsson, L.; Herber, R.; Kazantzis, G.; Nordberg, G.F.; Sabbioni, E. International project for producing reference values for concentrations of trace elements in human blood and urine - TRACY. Scand. J. Work Environ. Health, 1993, 19 Suppl 1, 19-26.
172. Predki, P.F.; Sarkar, B. Effect of replacement of "zinc finger" zinc on estrogen receptor DNA interactions. J. Biol. Chem., 1992, 267, 5842-6.
173. Martin, M.B.; Reiter, R.; Pham, T.; Avellanet Y.R.; Camara, J.; Lahm, M.; Pentecost, E.; Pratap, K.; Gilmore, B.A.; Divekar, S.; Dagata, R.S.; Bull, J.L.; Stoica, A. Estrogen-like activity of metals in Mcf-7 breast cancer cells. Endocrinology, 2003, 144, 2425-36
174. Choe, S.-Y.; Kim, S.-J.; Kim, H.-G..; Lee, J.H.; Choi, Y.; Lee, H.; Kim, Y. Evaluation of estrogenicity of major heavy metals. Sci. Total Environ., 2003, 312, 15-21.
175. Stoica, A.; Katzenellenbogen, B.S.; Martin, M.B. Activation of estrogen receptor-α by the heavy metal cadmium. Mol. Endocrinol., 2000, 14, 545-53.
176. Stoica, A.; Pentecost E.; Martin, M.B. Effects of arsenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells. Endocrinology, 2000, 141, 3595-602.
177. Stoica, A.; Pentecost E.; Martin, M.B. Effects of selenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells. J. Cell Biochem., 2000, 79, 282-92.
178. Johnson, M.D.; Kenney, N.; Stoica, A.; Hilakivi-Clarke, L., Singh, B.; Chepko, G.; Clarke, R.; Sholler, P.F.; Lirio, A.A.; Foss, C.; Reiter, R.; Trock, B.; Paik, S.; Martin, M.B. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med., 2003, 9, 1081-4.
179. McElroy, J.A.; Shafer, M.M.; Trentham-Dietz, A.; Hampton, J.M.; Newcomb, P.A. Cadmium exposure and breast cancer risk. J. Natl. Cancer Inst., 2006, 98, 869-73.
180. Cui, Y.; Vogt, S.; Olson, N.; Glass, A.G.; Rohan, T.E. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 1682-5.
181. Cavallo, F.; Gerber, M.; Marubini, E.; Richardson, S.; Barbieri, A.; Costa, A.; DeCarli, A.; Pujol, H. Zinc and copper in breast cancer. A joint study in northern Italy and southern France. Cancer, 1991, 67, 738-45.
182. Garland, M.; Morris, J.S.; Colditz, G.A.; Stampfer, M.J.; Spate, V.L.; Baskett, C.K.; Rosner, B.; Speizer, F.E.; Willett, W.C.; Hunter, D.J. Toenail trace element levels and breast cancer: A prospective study. Am. J. Epidemiol., 1996, 144, 653-60.
183. van 't Veer, P.; Strain, J.J.; Fernandez-Crehuet, J.; Martin, B.C.; Thamm, M., Kardinaal, A.F.M., Kohlmeier, L.; Huttunen, J.K.; Martin-Moreno, J.M.; Kok, F.J. Tissue antioxidants and postmenopausal breast cancer: The European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol. Biomarkers Prev., 1996, 5, 441-7.
184. Ghadirian, P.; Maisonneuve, P.; Perret, C.; Kennedy, G.; Boyle, P.; Krewski, D.; Lacroix, A. A case-control study of toenail selenium and cancer of the breast colon, and prostate. Cancer Detect. Prev., 2000, 24, 305-13.
185. Mannisto, S.; Alfthan, G.; Virtanen, M.; Kataja, V.; Uusitupa, M.; Pietinen, P. Toenail selenium and breast cancer - a case-control study in Finland. Eur. J. Clin. Nutr., 2000, 54, 98-103
186. Stellman, S.D.; Djordjevic, M. V.; Muscat J.E.; Gong, L.; Bernstein, D.; Citron, M.L.; White, A.; Kemeny, M.; Busch, E.; Nafziger, A.N. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol. Biomarkers Prev., 1998, 7, 489-96.
187. Pauwels, A.; Covaci, A.; Weyler, J.; Delbeke, L.; Dhont M.; De Sutter, P.; D'Hooghe, T.; Schepens, P.J.C. Comparison of persistent organic pollutant residues in serum and adipose tissue in a female population in Belgium, 1996-1998, Arch. Environ. Contam. Toxicol., 2000, 39, 265-70.
188. Rusiecki, J.A.; Matthews, A.; Sturgeon, S.; Sinha, R.; Pellizzari, E.; Zheng, T.; Baris, D. A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1113-24.
189. Archibeque-Engle, S.L.; Tessari, J.D.; Winn, D.T.; Keefe, T.J.; Nett, T.M., Zheng, T. Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J. Toxicol. Environ. Health, 1997, 52, 285-93.
190. Waliszewski, S.M.; Carvajal, O.; Infanzon, R.M.; Trujillo, P.; Hart, M.M. Copartition ratios of persistent organochlorine pesticides between human adipose tissue and blood serum lipids. Bull. Environ. Contam. Toxicol., 2004, 73, 732-8.
191. Waliszewski, S.M.; Bermudez, M.T.; Infanzon, R.M.; Silva, C.S.; Carvajal, O.; Trujillo, P.; Gomez Arroyo, S.; Villalobos Pietrini, R.; Saldaña, V.A.; Melo, G.; Esquivel, S.; Castro, F.; Ocampo, H.; Torres, J.; Hayward-Jones, P.M. Persistent organochlorine pesticide levels in breast adipose tissue in women with malignant and benign breast tumors. Bull. Environ. Contam. Toxicol., 2005, 75, 752-9.
192. Wolff, M.S.; Camann, D.; Gammon, M.; Stellman, S.D. Proposed PCB congener groupings for epidemiological studies. Environ. Health Perspect., 1997, 105, 13-4.
193. Hong, H.; Tong, W.; Fang, H.; Shi, L.; Xie, Q.; Wu, J.; Perkins, R.; Walker, J.D.; Branham, W.; Sheehan, D.M. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. Environ. Health Perspect., 2002, 110, 29-36.
194. Dees, C.; Askari, M.; Foster, J.S.; Ahamed, S.; Wimalasena, J. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Mol. Carcinog., 1997, 18, 107-14.
195. Rajapakse, N.; Silva, E.; Kortenkamp, A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ. Health Perspect., 2002, 110, 917-21.
196. Kortenkamp, A. Breast cancer, oestrogens and environmental pollutants: A re-evaluation from a mixture perspective. Int. J. Androl., 2006, 29, 193-8.
197. Russo, J.; Russo, I.H. Development of the human breast. Maturitas, 2004, 49, 2-15.
198. López-Carrillo, L.; Blair, A.; López-Cervantes, M.; Cebrián, M.; Rueda, C.; Reyes, R.; Mohar, A.; Bravo, J. Dichlorodiphenyl-trichloroethane serum levels and breast cancer risk: A case-control study from Mexico. Cancer Res., 1997, 57, 3728-32.
199. Mendonça, G.A.S.; Eluf-Neto, J.; Andrada-Serpa, M.J.; Carmo, P.A.O.; Barreto, H.H.C.; Inomata, O.N.K.; Kussumi, T.A. Organochlorines and breast cancer: A case-control study in Brazil. Int. J. Cancer, 1999, 83, 596-600.
200. Romieu, I.; Hernandez-Avila, M.; Lazcano-Ponce, E.; Weber, J.P.; Dewailly, E. Breast cancer, lactation history, and serum organochlorines. Am. J. Epidemiol., 2000, 152, 363-70.
201. Høyer, A.P.; Jørgensen, T.; Grandjean, P.; Hartvig, H.B. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control, 2000, 11, 177-84.
202. Miller, E.C.; Miller, J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 1981, 47, 2327-45.
203. Kuiper, G.G.J.M.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der Burg, B.; Gustafsson, J.-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology, 1998, 139, 4252-63.
204. Millikan, R.; DeVoto, E.; Duell, E.J.; Tse, C.-K.; Savitz, D.A.; Beach, J.; Edmiston, S.; Jackson, S.; Newman, B. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 1233-40.
205. Mitra, A.K.; Faruque, F.S.; Avis, A.L. Breast cancer and environmental risks: Where is the link? J. Environ. Health, 2004, 66, 24-32.
206. Rubin, C.H.; Lanier, A.; Kieszak, S.; Brock, J.W.; Koller, K.R.; Strosnider, H.; Needham, L.; Zahm, S.; Harpster, A. Breast cancer among Alaska Native women potentially exposed to environmental organochlorine chemicals. Int. J. Circumpolar Health, 2006, 65, 18-27.
207. Gatto, N.M.; Longnecker, M.P.; Press, M.F.; Sullivan-Halley, J.; McKean-Cowdin, R.; Bernstein, L. Serum organochlorines and breast cancer: A case-control study among African-American women. Cancer Causes Control, 2007, 18, 29-39.
208. Link, B.; Gabrio, T.; Zöllner, I.; Piechotowski, I.; Kouros, B. Sentinel health department project in Baden-Wuerttemberg (Germany) - a useful tool for monitoring children's health and environment. Int. J. Hyg. Environ. Health, 2007, 210, 351-5.
209. Kutz, F.W.; Wood, P.H.; Bottimore, D.P. Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev. Environ. Contam. Toxicol., 1991, 120, 1-82.
210. LaKind, J.S.; Wilkins, A.A.; Bates, M.N. Human breast biomonitoring and environmental chemicals: Use of breast tissues and fluids in breast cancer etiologic research. J. Expo. Sci. Environ. Epidemiol., 2007, 17, 525-40.
211. Barr, J.R.; Maggio, V.L.; Barr, D.B.; Turner, W.E.; Sjödin, A.; Sandau, C.D.; Pirkle, J.L.; Needham, L.L.; Patterson, D.G., Jr. New high-resolution mass spectrometric approach for the measurement of polychlorinated biphenyls and organochlorine pesticides in human serum. J. Chromatogr. B, 2003, 794, 137-48.
212. Needham, L.L.; Patterson, D.G., Jr.; Barr, D.B.; Grainger, J.; Calafat, A.M. Uses of speciation techniques in biomonitoring for assessing human exposure to organic environmental chemicals. Anal. Bioanal. Chem., 2005, 381, 397-404.
213. Weis, B.K.; Balshaw, D.; Barr, J.R.; Brown, D.; Ellisman, M.; Lioy, P.; Omenn, G.; Potter, J.D.; Smith, M.T.; Sohn, L.; Suk, W.A.; Sumner, S.; Swenberg, J.; Walt, D.R.; Watkins, S.; Thompson, C.; Wilson, S.H. Personalized exposure assessment: Promising approaches for human environmental health research. Environ. Health Perspect., 2005, 113, 840-8.
214. Steinmetz, R.; Young, P.C.M.; Caperell-Grant, A.; Gize, E.A.; Madhukar, B.V.; Ben-Jonathan, N.; Bigsby, R.M. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res., 1996, 56, 5403-9.
215. Cavalieri, E.L.; Rogan, E.G.; Chakravarti, D. Initiation of cancer and other diseases by catechol ortho-quinones: A unifying mechanism. Cell. Mol. Life Sci., 2002, 59, 665-81.
216. Longnecker, M.P.; Rogan, W.J.; Lucier, G. The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu. Rev. Public Health, 1997, 18, 211-44.
217. Glustrom, L.W.; Mitton-Fry, R.M.; Wuttke, D.S. Re: 1,1-Dichloro-2, 2-bis-(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies. J. Natl. Cancer Inst., 2002, 94, 1337-8.
218. Tsuda, H.; Naito, A.; Kim, C.K.; Fukamachi, K.; Nomoto, H.; Moore, M.A. Carcinogenesis and its modification by environmental endocrine disruptors: In vivo experimental and epidemiological findings. Jpn. J. Clin. Oncol., 2003, 33, 259-70.
219. Maervoet, J.; Covaci, A.; Schepens, P.; Sandau, C.D.; Letcher, R.J. A reassessment of the nomenclature of polychlorinated biphenyl (PCB) metabolites. Environ. Health Perspect., 2004, 112, 291-4.
220. Ballschmiter, K.; Bacher, R.; Mennel, A.; Fischer, R.; Riehle, U.; Swerev, M. The determination of chlorinated biphenyls, chlorinated dibenzodioxins, and chlorinated dibenzofurans by GC-MS. J. High Resol. Chromatogr., 1992, 15, 260-70.
221. Angerer, J.; Mannschreck, C.; Gündel, J. Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons. Int. Arch. Occup. Environ. Health, 1997, 70, 365-77.
222. 2-deoxyguanosine adduct: Absolute configuration and conformation. Proc. Natl. Acad. Sci. USA, 2004, 101, 1433-8.
223. Layton, D.W.; Bogen, K.T.; Knize, M.G.; Hatch, F.T.; Johnson, V.M.; Felton, J.S. Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research. Carcinogenesis, 1995, 16, 39-52.
224. Soto, A.M.; Sonnenschein, C.; Chung, K.L.; Fernandez, M.F.; Olea, N.; Serrano, F.O. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect., 1995, 103 Suppl 7, 113-22.